Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Atara Biotherapeutics Inc ATRA

Healthcare Biotechnology
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. Its pipeline products include Ebvallo (Tab-cel... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ATRA)

Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference

Business Wire 8 days ago

Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress

Business Wire 9 days ago

Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Business Wire November 5, 2024

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 4, 2024

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 6, 2024

Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Business Wire September 4, 2024

Atara Biotherapeutics Announces $36 Million Registered Direct Offering

Business Wire September 3, 2024

Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update

Business Wire August 12, 2024

Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference

Business Wire August 7, 2024
View More News ››

Opinion & Analysis (NDAQ:ATRA)

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Streetwise Reports May 28, 2020
View More Opinion ››

Bullboard Posts (NDAQ:ATRA)

ATRA....still moving higher post P.O

Now $10.64 You just never know what those Maggots are up to.....too many tricks up their sleeves They will always win.....you will...
Iseneschal - September 5, 2024

ATRA.....now up over $2/sh

go figure....skating !
Iseneschal - September 4, 2024

ATRA......P.O NR from yesterdays close....and it's still up?

  Atara Biotherapeutics Announces $36 Million Registered Direct Offering   2024-09-03 13:16 ET - News Release   ...
Iseneschal - September 4, 2024

RE:ATRA.....recent RS climbing "The Wall"

Wortha repeat....Hell ya !!!!! $14 HOLLA !!!!! On a NR this a.m!!!! Atara Biotherapeutics Announces U.S. FDA Acceptance and...
Iseneschal - July 17, 2024

RE:ATRA.....recent RS climbing "The Wall"

LoL......FOMO's entering the fray N.H.O.D  & H.O.D post RS No selling til over $25
Iseneschal - July 16, 2024

ATRA.....recent RS climbing "The Wall"

could be "A close shave" currently at $12....a break of previous high would be meaningful....$12.46
Iseneschal - July 16, 2024
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »